The impact of coexisting COPD on survival of patients with early-stage non-small cell lung cancer undergoing surgical resection

Chest

Volumn 145, Issue 2, 2014, Pages 346-353

  Zhai, Rihong ^a   Yu, Xiaojin ^a   Shafer, Andrea ^b   Wain, John C ^c   Christiani, David C ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b Department of Medicine ^*  (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CANCER SURVIVAL; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HIGH RISK PATIENT; HUMAN; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; RECURRENCE RISK; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; SMOKING;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; COMORBIDITY; DISEASE PROGRESSION; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LONGITUDINAL STUDIES; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PNEUMONECTOMY; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84893697139     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.13-1176     Document Type: Article

References (43)

1. Mannino DM , Buist AS. Global burden of COPD: Risk factors, prevalence, and future trends. Lancet. 2007 ; 370 ( 9589 ): 765-773.
2. Buist AS , McBurnie MA , Vollmer WM , et al ; BOLD Collaborative Research Group. International variation in the prevalence of COPD (the BOLD Study): A population-based prevalence study. Lancet. 2007 ; 370 ( 9589 ): 741-750.
3. Decramer M, Janssens W , Miravitlles M. Chronic obstructive pulmonary disease. Lancet. 2012 ; 379 ( 9823 ): 1341-1351.
4. Rabe KF , Hurd S, Anzueto A, et al; Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007 ; 176 ( 6 ): 532-555.
5. Raviv S , Hawkins KA , DeCamp MM Jr , Kalhan R. Lung cancer in chronic obstructive pulmonary disease: Enhancing surgical options and outcomes. Am J Respir Crit Care Med. 2011 ; 183 ( 9 ): 1138-1146.
6. de Torres JP , Marín JM , Casanova C , et al. Lung cancer in patients with chronic obstructive pulmonary disease-incidence and predicting factors. Am J Respir Crit Care Med. 2011 ; 184 ( 8 ): 913-919.
7. Young RP , Hopkins RJ , Christmas T , Black PN , Metcalf P , Gamble GD. COPD prevalence is increased in lung cancer, independent of age, sex and smoking history. Eur Respir J. 2009 ; 34 ( 2 ): 380-386.
8. Mayne ST , Buenconsejo J, Janerich DT. Previous lung disease and risk of lung cancer among men and women nonsmokers. Am J Epidemiol. 1999 ; 149 ( 1 ): 13-20.
9. Turner MC , Chen Y , Krewski D , Calle EE , Thun MJ. Chronic obstructive pulmonary disease is associated with lung cancer mortality in a prospective study of never smokers. Am J Respir Crit Care Med. 2007 ; 176 ( 3 ): 285-290.
10. Celli B, Decramer M, Kesten S, Liu D, Mehra S, Tashkin DP; UPLIFT Study Investigators. Mortality in the 4-year trial of tiotropium (UPLIFT) in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2009; 180( 10): 948-955.
11. Mannino DM , Aguayo SM , Petty TL , Redd SC. Low lung function and incident lung cancer in the United States: Data from the First National Health and Nutrition Examination Survey follow-up. Arch Intern Med. 2003; 163( 12): 1475-1480.
12. Wasswa-Kintu S , Gan WQ , Man SF , Pare PD , Sin DD. Relationship between reduced forced expiratory volume in one second and the risk of lung cancer: A systematic review and meta-analysis. Thorax. 2005 ; 60 ( 7 ): 570-575.
13. Tammemagi CM, Neslund-Dudas C, Simoff M, Kvale P. Impact of comorbidity on lung cancer survival. Int J Cancer. 2003 ; 103 ( 6 ): 792-802.
14. Kiri VA , Soriano J , Visick G , Fabbri L. Recent trends in lung cancer and its association with COPD: An analysis using the UK GP Research Database. Prim Care Respir J. 2010 ; 19 ( 1 ): 57-61.
15. Kondo R , Yoshida K , Eguchi T , et al. Clinical features of lung cancer in smokers with light and mild chronic obstructive pulmonary disease: A retrospective analysis of Japanese surgical cases. Eur J Cardiothorac Surg. 2011 ; 40 ( 6 ): 1439-1443.
16. Sekine Y , Suzuki H , Yamada Y , Koh E , Yoshino I. Severity of chronic obstructive pulmonary disease and its relationship to lung cancer prognosis after surgical resection. Thorac Cardiovasc Surg. 2013 ; 61 ( 2 ): 124-130.
17. Kawaguchi T , Matsumura A, Fukai S, et al. Japanese ethnicity compared with Caucasian ethnicity and never-smoking status are independent favorable prognostic factors for overall survival in non-small cell lung cancer: A collaborative epidemiologic study of the National Hospital Organization Study Group for Lung Cancer (NHSGLC) in Japan and a Southern California Regional Cancer Registry databases. J Thorac Oncol. 2010 ; 5 ( 7 ): 1001-1010.
18. Soo RA, Loh M, Mok TS, et al. Ethnic differences in survival outcome in patients with advanced stage non-small cell lung cancer: Results of a meta-analysis of randomized controlled trials. J Thorac Oncol. 2011 ; 6 ( 6 ): 1030-1038.
19. López-Encuentra A , Astudillo J , Cerezal J , Gonzalez-Aragoneses F , Novoa N , Sánchez-Palencia A ; Bronchogenic Carcinoma Cooperative Group of the Spanish Society of Pneumology and Thoracic Surgery (GCCB-S). Prognostic value of chronic obstructive pulmonary disease in 2994 cases of lung cancer. Eur J Cardiothorac Surg. 2005 ; 27 ( 1 ): 8-13.
20. Chansky K , Sculier JP , Crowley JJ , Giroux D , Van Meerbeeck J , Goldstraw P ; International Staging Committee and Participating Institutions. The International Association for the Study of Lung Cancer Staging Project: Prognostic factors and pathologic TNM stage in surgically managed non-small cell lung cancer. J Thorac Oncol. 2009 ; 4 ( 7 ): 792-801.
21. Heist RS, Zhai R, Liu G, et al. VEGF polymorphisms and survival in early-stage non-small-cell lung cancer. J Clin Oncol. 2008 ; 26 ( 6 ): 856-862.
22. Gershon AS , Guan J , Victor JC , Goldstein R , To T. Quantifying health services use for chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013 ; 187 ( 6 ): 596-601.
23. Schnell K , Weiss CO , Lee T , et al. The prevalence of clinically-relevant comorbid conditions in patients with physiciandiagnosed COPD: A cross-sectional study using data from NHANES 1999-2008. BMC Pulm Med. 2012 ; 12 : 26.
24. Barr RG , Herbstman J , Speizer FE , Camargo CA Jr. Validation of self-reported chronic obstructive pulmonary disease in a cohort study of nurses. Am J Epidemiol. 2002 ; 155 ( 10 ): 965-971.
25. Straus SE , McAlister FA , Sackett DL , Deeks JJ ; CARECOAD2 Group. Clinical Assessment of the Reliability of the Examination-Chronic Obstructive Airways Disease. Accuracy of history, wheezing, and forced expiratory time in the diagnosis of chronic obstructive pulmonary disease. J Gen Intern Med. 2002 ; 17 ( 9 ): 684-688.
26. Eisner MD , Trupin L , Katz PP , et al. Development and validation of a survey-based COPD severity score. Chest. 2005 ; 127 ( 6 ): 1890-1897.
27. Lee G , Walser TC , Dubinett SM. Chronic inflammation, chronic obstructive pulmonary disease, and lung cancer. Curr Opin Pulm Med. 2009 ; 15 ( 4 ): 303-307.
28. O'Callaghan DS , O'Donnell D , O'Connell F , O'Byrne KJ. The role of inflammation in the pathogenesis of non-small cell lung cancer. J Thorac Oncol. 2010 ; 5 ( 12 ): 2024-2036.
29. Bosken CH , Wei Q , Amos CI , Spitz MR. An analysis of DNA repair as a determinant of survival in patients with non-smallcell lung cancer. J Natl Cancer Inst. 2002 ; 94 ( 14 ): 1091-1099.
30. Anderson GP , Bozinovski S. Acquired somatic mutations in the molecular pathogenesis of COPD. Trends Pharmacol Sci. 2003 ; 24 ( 2 ): 71-76.
31. Zhou W , Gurubhagavatula S , Liu G , et al. Excision repair cross-complementation group 1 polymorphism predicts overall survival in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy. Clin Cancer Res. 2004 ; 10 ( 15 ): 4939-4943.
32. Demedts IK, Demoor T , Bracke KR, Joos GF , Brusselle GG. Role of apoptosis in the pathogenesis of COPD and pulmonary emphysema. Respir Res. 2006 ; 7 : 53.
33. Singhal S, Vachani A, Antin-Ozerkis D, Kaiser LR, Albelda SM. Prognostic implications of cell cycle, apoptosis, and angiogenesis biomarkers in non-small cell lung cancer: A review. Clin Cancer Res. 2005 ; 11 ( 11 ): 3974-3986.
34. Liloglou T , Bediaga NG , Brown BR , Field JK , Davies MP. Epigenetic biomarkers in lung cancer [published online ahead of print April 27, 2012]. Cancer Lett. doi:10.1016/j. canlet.2012.04.018.
35. Qiu W , Baccarelli A , Carey VJ , et al. Variable DNA methylation is associated with chronic obstructive pulmonary disease and lung function. Am J Respir Crit Care Med. 2012 ; 185 ( 4 ): 373-381.
36. Corsonello A , Antonelli Incalzi R , Pistelli R , Pedone C , Bustacchini S, Lattanzio F. Comorbidities of chronic obstructive pulmonary disease. Curr Opin Pulm Med. 2011; 17( suppl 1): S21-S28.
37. Kawai H , Tada A , Kawahara M , et al ; Japan National Hospital Study Group for Lung Cancer. Smoking history before surgery and prognosis in patients with stage IA non-small-cell lung cancer-a multicenter study. Lung Cancer. 2005 ; 49 ( 1 ): 63-70.
38. Papi A , Casoni G , Caramori G , et al. COPD increases the risk of squamous histological subtype in smokers who develop non-small cell lung carcinoma. Thorax. 2004 ; 59 ( 8 ): 679-681.
39. Parsons A, Daley A, Begh R, Aveyard P. Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: Systematic review of observational studies with metaanalysis. BMJ. 2010 ; 340 : B5569.
40. Pesch B , Kendzia B , Gustavsson P , et al. Cigarette smoking and lung cancer-relative risk estimates for the major histological types from a pooled analysis of case-control studies. Int J Cancer. 2012 ; 131 ( 5 ): 1210-1219.
41. Nakamura H, Ando K, Shinmyo T , et al. Female gender is an independent prognostic factor in non-small-cell lung cancer: A meta-analysis. Ann Thorac Cardiovasc Surg. 2011 ; 17 ( 5 ): 469-480.
42. Cote CG , Chapman KR. Diagnosis and treatment considerations for women with COPD. Int J Clin Pract. 2009 ; 63 ( 3 ): 486-493.
43. Howington JA , Blum MG , Chang AC , Balekian AA , Murthy SC. Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013 ;143(5-suppl):e278S-e313S.